In the current study, it was hypothesized that radiation sensitivity will be enhanced after effective inhibition of IGF-1r through siRNA gene-silencing technology, which will result in a higher therapeutic efficacy in treating ESCC patients. This evidence concerns the gene IGF1R and esophageal squamous cell carcinoma.